Status:

TERMINATED

Comparison Between IORT and Postoperative Radiotherapy in Breast Conserving Surgery

Lead Sponsor:

Xiangyun Zong

Conditions:

Quality of Life

Eligibility:

FEMALE

18-70 years

Phase:

NA

Brief Summary

To compare the satisfaction with conserved breast, acute and chronic postoperative complications and tumor control between intraoperative radiotherapy(IORT) and traditional postoperative radiotherapy ...

Eligibility Criteria

Inclusion

  • Primary invasive breast cancer confirmed by pathology.
  • Maximum tumor diameter ≤3.5cm.
  • Clinical lymph nodes are negative.
  • Single or multiple tumors are located on the same side of the nipple and in the same quadrant.
  • ECOG status score ≤ 2.
  • With informed Consents.

Exclusion

  • Previous history of breast cancer or other malignant tumors.
  • Inflammatory breast cancer; 3. Previous radiotherapy history.
  • Other diseases affecting radiotherapy, such as connective tissue disease, heart disease, lung disease and so on.
  • Patients who are not going to have the axillary lymph node surgery (including SLN and ALND) were excluded.

Key Trial Info

Start Date :

March 1 2021

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

February 28 2025

Estimated Enrollment :

80 Patients enrolled

Trial Details

Trial ID

NCT04789889

Start Date

March 1 2021

End Date

February 28 2025

Last Update

June 2 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Shanghai Jiao Tong University Affiliated Sixth People's Hospital

Shanghai, Shanghai Municipality, China, 200233